Varex Imaging Corporation (VREX) Misses Q3 EPS by 19c
Varex Imaging Corporation (NASDAQ: VREX) reported Q3 EPS of ($0.20), $0.19 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $171 million versus the consensus estimate of $171.09 million.
3QFY20 Summary
- Revenues were $171 million
- GAAP gross margin was 15% | non-GAAP gross margin* was 26%
- GAAP operating earnings margin was (15.7)% | non-GAAP operating earnings margin* was (0.7)%
- GAAP net loss was ($0.73) per diluted share | non-GAAP net loss* was ($0.20) per diluted share
“During the third quarter of fiscal year 2020, the impact of COVID-19 resulted in declining sales and a sizeable unfavorable shift in product mix that reduced our revenues, margins and profitability. While sales of CT tubes and other radiographic products used in COVID-19 related diagnostic imaging applications increased significantly, total revenues declined 13% from the year ago quarter due to sales declines in other products, such as those for oncology, dental and industrial applications,” said Sunny Sanyal, Chief Executive Officer of Varex.
In response to the decline in revenues and gross margin, Varex has taken a number of actions that are expected to reduce annual operating costs by more than $25 million, including:
- Accelerating the previously announced closure of its Santa Clara facility, with most assembly operations shut down in June.
- Discontinuing certain low margin, low demand products resulting in a $16 million pretax non-cash charge during the third quarter of fiscal year 2020 for the write-down of associated inventory and restructuring activity.
- Downsizing the workforce by eliminating 94 positions at the end of July, which when combined with other actions, is expected to result in an overall workforce reduction of about 10% in calendar year 2020.
- Closely managing discretionary spending and capital expenditures.
“We believe that these and other actions, as well as a continued focus on pursuing productivity gains, will better position Varex when the imaging markets recover from the downturn caused by COVID-19,” said Sanyal.
For earnings history and earnings-related data on Varex Imaging Corporation (VREX) click here.
